Philadelphia Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27M Hold
2,415
0.1% 105
2025
Q1
$1.53M Hold
2,415
0.13% 94
2024
Q4
$1.72M Hold
2,415
0.13% 92
2024
Q3
$2.54M Buy
2,415
+1,250
+107% +$1.31M 0.18% 79
2024
Q2
$1.22M Sell
1,165
-8
-0.7% -$8.41K 0.1% 102
2024
Q1
$1.13M Buy
1,173
+15
+1% +$14.4K 0.09% 112
2023
Q4
$1.02M Hold
1,158
0.1% 116
2023
Q3
$953K Hold
1,158
0.1% 117
2023
Q2
$832K Hold
1,158
0.08% 126
2023
Q1
$951K Hold
1,158
0.1% 120
2022
Q4
$835K Sell
1,158
-250
-18% -$180K 0.09% 125
2022
Q3
$970K Hold
1,408
0.11% 106
2022
Q2
$832K Sell
1,408
-4,224
-75% -$2.5M 0.09% 118
2022
Q1
$3.93M Buy
5,632
+4,232
+302% +$2.96M 0.31% 67
2021
Q4
$884K Hold
1,400
0.06% 134
2021
Q3
$847K Hold
1,400
0.06% 139
2021
Q2
$782K Hold
1,400
0.05% 153
2021
Q1
$662K Buy
+1,400
New +$662K 0.05% 152
2020
Q3
Sell
-404
Closed -$252K 200
2020
Q2
$252K Sell
404
-96
-19% -$59.9K 0.03% 162
2020
Q1
$244K Sell
500
-1,058
-68% -$516K 0.03% 150
2019
Q4
$585K Sell
1,558
-93
-6% -$34.9K 0.05% 146
2019
Q3
$458K Hold
1,651
0.04% 162
2019
Q2
$517K Buy
+1,651
New +$517K 0.05% 162
2018
Q4
Sell
-650
Closed -$263K 194
2018
Q3
$263K Buy
+650
New +$263K 0.02% 185
2017
Q4
Sell
-19,136
Closed -$8.56M 229
2017
Q3
$8.56M Buy
19,136
+17,056
+820% +$7.63M 0.7% 48
2017
Q2
$1.02M Sell
2,080
-500
-19% -$246K 0.09% 120
2017
Q1
$1M Hold
2,580
0.08% 120
2016
Q4
$947K Hold
2,580
0.08% 129
2016
Q3
$1.04M Hold
2,580
0.09% 120
2016
Q2
$901K Hold
2,580
0.08% 123
2016
Q1
$930K Sell
2,580
-625
-20% -$225K 0.08% 109
2015
Q4
$1.75M Hold
3,205
0.15% 82
2015
Q3
$1.49M Buy
3,205
+1,075
+50% +$500K 0.13% 88
2015
Q2
$4.18K Sell
2,130
-3,020
-59% -$5.92K 0.02% 168
2015
Q1
$2.33M Hold
5,150
0.18% 81
2014
Q4
$2.11M Hold
5,150
0.17% 73
2014
Q3
$1.86M Sell
5,150
-1,975
-28% -$712K 0.12% 80
2014
Q2
$2.01M Buy
7,125
+600
+9% +$170K 0.13% 78
2014
Q1
$1.96M Buy
6,525
+5,525
+553% +$1.66M 0.12% 71
2013
Q4
$275K Hold
1,000
0.02% 175
2013
Q3
$313K Buy
+1,000
New +$313K 0.02% 152